ABOS Acumen Pharmaceuticals, Inc.
$0.21
Acumen Pharmaceuticals, Inc. (ABOS) Earnings News
Earnings press releases, previews and reviews for Acumen Pharmaceuticals, Inc. (ABOS), newest first. Our most recent is review: Acumen Beats on a Share-Count-Aided Loss, but November's Binary Sabirnetug Readout and a Thin Cash Runway Are the Real Story.
Monday
October 26, 2026
9:57 AM ET
Acumen Beats on a Share-Count-Aided Loss, but November's Binary Sabirnetug Readout and a Thin Cash Runway Are the Real Story
Earnings Whispers · Review
Monday
October 26, 2026
7:00 AM ET
Acumen Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Highlights
Tuesday
October 20, 2026
9:59 AM ET
Acumen's Q3 Report Is a Runway Check Ahead of Its Make-or-Break Altitude Readout
Earnings Whispers · Preview
Monday
October 19, 2026
4:00 PM ET
Acumen Pharmaceuticals to Report Third Quarter Financial Results on October 26, 2026
Wednesday
August 12, 2026
7:00 AM ET
Acumen Pharmaceuticals Reports Second Quarter 2026 Financial Results and Business Highlights
Wednesday
August 5, 2026
4:00 PM ET
Acumen Pharmaceuticals to Report Second Quarter Financial Results on August 12, 2026
Tuesday
May 12, 2026
7:00 AM ET
Acumen Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Highlights
Tuesday
May 5, 2026
4:00 PM ET
Acumen Pharmaceuticals to Report First Quarter Financial Results on May 12, 2026